| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $8,266,252 | 13 | 100 |
| FINNEY ELISHA W | director | 0 | $0 | 2 | $249,418 | $-249,418 |
| Greenberg David C. | director | 0 | $0 | 1 | $297,934 | $-297,934 |
| Sousa Ben | Chief Information Officer | 0 | $0 | 1 | $401,209 | $-401,209 |
| Sanzone Virginia Ruth | VP, General Counsel | 0 | $0 | 3 | $1.26M | $-1.26M |
| Voigtlander Christian B. | Chief Operating Officer | 0 | $0 | 1 | $1.63M | $-1.63M |
| Woolson Daniel | VP, GM-Infusion Capital | 0 | $0 | 3 | $1.7M | $-1.7M |
| Bonnell Brian Michael | Chief Financial Officer | 0 | $0 | 2 | $2.72M | $-2.72M |
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. …
Over the last 12 months, insiders at ICU Medical, Inc. have bought $0 and sold $8.27M worth of ICU Medical, Inc. stock.
On average, over the past 5 years, insiders at ICU Medical, Inc. have bought $1.93M and sold $47.71M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,200 shares for transaction amount of $151,698 was made by Greenberg David C. (director) on 2025‑08‑27.
| 2026-09-03 | Sale | Sanzone Virginia Ruth | VP, General Counsel | 4,856 0.0197% | $168.69 | $819,150 | -2.99% | |
| 2026-09-01 | Sale | Bonnell Brian Michael | Chief Financial Officer | 6,381 0.0262% | $175.00 | $1.12M | -5.38% | |
| 2026-08-31 | Sale | Bonnell Brian Michael | Chief Financial Officer | 9,307 0.0372% | $172.79 | $1.61M | -6.43% | |
| 2026-08-13 | Sale | Woolson Daniel | VP, GM-Infusion Capital | 5,417 0.0215% | $181.33 | $982,265 | -10.81% | |
| 2026-08-12 | Sale | Sousa Ben | Chief Information Officer | 2,250 0.009% | $178.32 | $401,209 | -8.90% | |
| 2026-08-11 | Sale | Voigtlander Christian B. | Chief Operating Officer | 8,929 0.0359% | $182.93 | $1.63M | -10.24% | |
| 2026-08-11 | Sale | FINNEY ELISHA W | director | 378 0.0015% | $182.48 | $68,978 | -10.24% | |
| 2026-05-22 | Sale | Woolson Daniel | President | 2,123 0.0086% | $132.21 | $280,685 | +20.65% | |
| 2026-05-14 | Sale | Sanzone Virginia Ruth | VP, General Counsel | 2,447 0.0099% | $124.08 | $303,624 | +29.87% | |
| 2026-05-12 | Sale | Greenberg David C. | director | 2,424 0.0097% | $122.91 | $297,934 | +29.38% | |
| 2025-11-25 | Sale | Woolson Daniel | VP, GM-Infusion Capital | 2,897 0.0126% | $152.35 | $441,364 | -1.73% | |
| 2025-11-11 | Sale | Sanzone Virginia Ruth | VP, General Counsel | 930 0.0038% | $142.34 | $132,381 | +3.70% | |
| 2025-11-11 | Sale | FINNEY ELISHA W | director | 1,285 0.0052% | $140.42 | $180,440 | +3.70% | |
| 2025-08-27 | Greenberg David C. | director | 1,200 0.0049% | $126.42 | $151,698 | +9.67% | ||
| 2025-08-14 | Jain Vivek | Chairman and CEO | 21,929 0.0896% | $112.84 | $2.47M | +21.66% | ||
| 2025-05-30 | Sale | Sanzone Virginia Ruth | VP, General Counsel | 700 0.0028% | $133.62 | $93,537 | -3.20% | |
| 2025-05-28 | Sale | Voigtlander Christian B. | Chief Operating Officer | 4,985 0.02% | $128.50 | $640,576 | +1.61% | |
| 2025-05-27 | Sale | Voigtlander Christian B. | Chief Operating Officer | 4,945 0.0202% | $131.00 | $647,795 | +0.08% | |
| 2025-05-23 | Sale | Voigtlander Christian B. | Chief Operating Officer | 4,959 0.0203% | $130.00 | $644,670 | +1.10% | |
| 2025-05-22 | Sale | Voigtlander Christian B. | Chief Operating Officer | 4,959 0.02% | $130.03 | $644,832 | -0.27% |
| Greenberg David C. | director | 7960 0.0318% | $1.29M | 1 | 3 | +9.67% |
| LOPEZ GEORGE A | director | 877343 3.5084% | $141.98M | 9 | 248 | +23.53% |
| Jain Vivek | Chairman and CEO | 130149 0.5205% | $21.06M | 2 | 30 | +14.08% |
| SHERMAN RICHARD MD | director | 69199 0.2767% | $11.2M | 1 | 16 | |
| SWINNEY ROBERT S | director | 20816 0.0832% | $3.37M | 1 | 34 | |
| BROWN JACK | director | 16813 0.0672% | $2.72M | 1 | 3 | |
| Lamb Scott E | Chief Financial Officer, | 13309 0.0532% | $2.15M | 5 | 13 | +1.7% |
| OBRIEN FRANCIS J | Chief Financial Officer | 8046 0.0322% | $1.3M | 6 | 4 | +4.99% |
| KOVALCHIK MICHAEL T | director | 3784 0.0151% | $612,364.72 | 1 | 8 | |
| CONNORS JOHN J | director | 1840 0.0074% | $297,767.20 | 1 | 15 | |
| RIGGS STEVEN | VP Operations | 1326 0.0053% | $214,586.58 | 9 | 31 | +4% |
| COSTELLO RICHARD A | Vice President Sales | 285 0.0011% | $46,121.55 | 8 | 39 | +4.38% |
| BURCAR ALISON D | Vice President and Gen'l Mgr. | 0 0% | $0 | 9 | 24 | +4% |
| SAUCEDO JOSEPH R | director | 0 0% | $0 | 3 | 26 | +13.62% |
| Increased Positions | 157 | +51.99% | 3M | +10.67% |
| Decreased Positions | 131 | -43.38% | 3M | -11.72% |
| New Positions | 58 | New | 1M | New |
| Sold Out Positions | 32 | Sold Out | 415,909 | Sold Out |
| Total Postitions | 328 | +8.61% | 26M | -1.05% |
| Blackrock, Inc. | $487,846.00 | 14.09% | 3.52M | -41,477 | -1.16% | 2025-09-30 |
| Vanguard Group Inc | $363,640.00 | 10.5% | 2.62M | -33,506 | -1.26% | 2025-09-30 |
| Janus Henderson Group Plc | $342,659.00 | 9.89% | 2.47M | +3,390 | +0.14% | 2025-09-30 |
| Fuller & Thaler Asset Management, Inc. | $191,886.00 | 5.54% | 1.39M | -4,811 | -0.35% | 2025-09-30 |
| Millennium Management Llc | $150,862.00 | 4.36% | 1.09M | +690,694 | +173.4% | 2025-09-30 |
| State Street Corp | $127,049.00 | 3.67% | 917,125 | -10,674 | -1.15% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $120,936.00 | 3.49% | 872,993 | +126,072 | +16.88% | 2025-09-30 |
| Ameriprise Financial Inc | $111,315.00 | 3.21% | 803,542 | +203,746 | +33.97% | 2025-09-30 |
| Schroder Investment Management Group | $110,367.00 | 3.19% | 796,704 | +160,380 | +25.2% | 2025-09-30 |
| Jpmorgan Chase & Co | $93,698.00 | 2.71% | 676,370 | -80,013 | -10.58% | 2025-09-30 |